| 询价 | |
| M00270 | |
|
|
|
|
|
|
|
|
|
| Product Description | Recombinant HEK293 cells stably overexpress human parathyroid hormone 2 receptor (PTH2) on the surface and contain high levels of G protein Gαs and Gαq to couple with the receptor in downstream signaling pathways. |
| Culture Properties | Adherent. |
| Stability | Stable through more than 16 passages with no significant changes in assay performance or expression profile. |
| Size | Two vials of frozen cells (>1×106 per vial in 1 mL). |
| Storage | Store cells in liquid nitrogen immediately upon receipt. Thaw and recover cells within one year from the date received. |
| Culture Medium | DMEM, 10% FBS, 300 μg/ml Geneticin (Cat. No. 10131-035, Life Technologies), 50 μg/ml Hygromycin B (Cat. No. 10687010, Invitrogen), 100 μg/ml Zeocin (Cat. No. R250-01, Life Technologies) |
| Complete Growth Medium | Complete Growth Medium: DMEM, 10% FBS. |
| Freeze Medium-DATA | 50% DMEM (Cat. No. 10566, Life Technologies), 45% FBS (Cat. No. 10099-141, Gibco), 5% DMSO (Cat. No. D2650, Sigma). |
Figure 1. PTH (1-34)-induced luciferase expression in HEK293/PTH2/CRE-Luc cells. After stimulation by agonist PTH (1-34), the cells are determined with Fire-Lumi™ Luciferase Assay System (Cat. No. L00877C-100, Genscript) and the relative luminescence units (RLU) were recorded by plate reader (Pherastar, BMG). The RLU were plotted against the log of the cumulative doses of PTH (1-34) (Mean ± SEM, n = 3). The EC50 of PTH (1-34) on cells was 0.68 nM.
»
Figure 2. Dose dependent stimulation of intracellular cAMP accumulation upon treatment with PTH (1-34) in HEK293/PTH2/CRE-Luc cells. d2 acceptor fluorophore-labeled cAMP (Cat. No. 62AM4PEC; Revvity) and intracellular cAMP in HEK293/PTH2/CRE-Luc cells competitively bind with Europium Cryptate-labeled anti-cAMP monoclonal antibody. The FRET signal decreases as the intracellular cAMP concentration rises and was measured by plate reader (Pherastar, BMG). The EC50 of PTH (1-34) on cells was 23.07 nM. »
For research use only. Not intended for human or animal clinical trials, therapeutic or diagnostic use.
